Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice.

Autor: Haupt R; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA.; Center for Pathogen Research, School of Medicine, University of Maryland, Baltimore, MD, USA.; Therapeutic Discovery Branch, Molecular Biology Division, USAMRIID, Fort Detrick, MD, USA., Baracco L; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA.; Center for Pathogen Research, School of Medicine, University of Maryland, Baltimore, MD, USA., Harberts EM; Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA., Loganathan M; Department of Microbiology, Icahn School of Medicine, New York, NY, USA., Kerstetter LJ; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA., Krammer F; Department of Microbiology, Icahn School of Medicine, New York, NY, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Coughlan L; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA.; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, MD, 21201, USA., Ernst RK; Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA., Frieman MB; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, USA. mfrieman@som.umaryland.edu.; Center for Pathogen Research, School of Medicine, University of Maryland, Baltimore, MD, USA. mfrieman@som.umaryland.edu.

Publikováno v: Scientific reports [Sci Rep] 2023 Jan 13; Vol. 13 (1), pp. 715. Date of Electronic Publication: 2023 Jan 13.